WPRIM Management System> DCMS> Blood Research> 2017> 52> 4

Volume: 52 Issue: 4

1. Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab. Page:337—339
2. Comparison of the acute erythropoietic capacities of erythropoietin and U-74389G in terms of hemoglobin levels. Page:334—337
3. Does the c.-273T>C variant in the upstream region of the HBB gene cause a thalassemia phenotype?. Page:332—334
4. Differential diagnosis of primary cutaneous CD4+ small/medium T-cell lymphoproliferative lesions: A report of three cases. Page:326—329
5. A case of primary plasma cell leukemia exhibiting hemophagocytic plasma cells relapsed with multiple cutaneous plasmacytoma. Page:324—326
6. Post-liver transplant myeloid maturation arrest. Page:321—324
7. Successful treatment of a patient with myelodysplastic syndrome accompanied by pyoderma gangrenosum and Behçet's disease using allogeneic stem cell transplantation. Page:319—321
8. Human parvovirus B19 and parvovirus 4 among Iranian patients with hemophilia. Page:311—315
9. Is long term storage of cryopreserved stem cells for hematopoietic stem cell transplantation a worthwhile exercise in developing countries?. Page:307—310
10. The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study. Page:300—306
11. STAT3 expression is associated with poor survival in non-elderly adult patients with newly diagnosed multiple myeloma. Page:293—299
12. Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology. Page:285—292
13. Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era. Page:276—284
14. Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma. Page:270—275
15. Interleukin-1B (IL-1B-31 and IL-1B-511) and interleukin-1 receptor antagonist (IL-1Ra) gene polymorphisms in primary immune thrombocytopenia. Page:264—269
16. Management of immune thrombocytopenia: Korean experts recommendation in 2017. Page:254—263
17. Brentuximab vedotin: clinical updates and practical guidance. Page:243—253
18. Sinusoidal infiltration of hepatosplenic lymphoma in liver and bone marrow. Page:242—242
19. A young man with acute respiratory distress syndrome: eosinophilia is not always “benign”. Page:329—332
20. Transplantation of human umbilical cord blood CD34⁺ cells into the liver of newborn NOD/SCID/IL-2Rγ null (NSG) mice after busulfan conditioning. Page:316—319
21. Myelodysplastic syndrome with occult diffuse large B-cell lymphoma. Page:241—241
22. Pseudo-Chediak-Higashi inclusions in a case of acute lymphoblastic leukemia. Page:240—240
23. Unravelling the genomic landscape of leukemia using NGS techniques: the challenge remains. Page:237—239
24. IL-1B-31 and IL-1Ra polymorphisms associated with increased host susceptibility to immune thrompocytopenia. Page:235—236